Cargando…

High mobility group box 1 in diabetic nephropathy

Type 2 diabetes (T2D) is a complex disorder caused by the combined effects of genetic inheritance and environmental factors. The abnormal secretion of albumin via urine is the characteristic feature of a diabetic nephropathy (DN) patient. Moreover, the detection of this observable characteristic fea...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shi, Haitao, Che, Yingqi, Bai, Lin, Zhang, Jinling, Fan, Jingxu, Mao, Huiling
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2017
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5609311/ https://www.ncbi.nlm.nih.gov/pubmed/28962177 http://dx.doi.org/10.3892/etm.2017.4826

Ejemplares similares

The association between high mobility group box 1 chromatin protein and mitotic chromosomes in glioma cells
por: Jia, Liyun, et al.
Publicado: (2020)

High-Mobility Group Box 1 Protein Signaling in Painful Diabetic Neuropathy
por: Thakur, Vikram, et al.
Publicado: (2020)

High-mobility group box 1: role in ARDS
por: Ishizaka, A, et al.
Publicado: (2005)

High‐Mobility Group Box‐1 and Liver Disease
por: Gaskell, Harriet, et al.
Publicado: (2018)

High Mobility Group Box 1 in Human Cancer
por: Rapoport, Bernardo L., et al.
Publicado: (2020)

Involvement of High Mobility Group Box 1 Protein in Optic Nerve Damage in Diabetes
por: Mohammad, Ghulam, et al.
Publicado: (2022)

High mobility group box 1: as a 'testament' mediator
por: Maruyama, I, et al.
Publicado: (2005)

The Role of High Mobility Group Box 1 in Innate Immunity
por: Lee, Shin-Ae, et al.
Publicado: (2014)

High Mobility Group Box Protein-1 in Wound Repair
por: Ranzato, Elia, et al.
Publicado: (2012)

High-Mobility Group Box 1 in Dry Eye Inflammation
por: Lema, Carolina, et al.
Publicado: (2018)

The Role of High Mobility Group Box 1 in Ischemic Stroke
por: Ye, Yingze, et al.
Publicado: (2019)

Role of High-Mobility Group Box-1 in Liver Pathogenesis
por: Khambu, Bilon, et al.
Publicado: (2019)

High Mobility Group Box 1 Protein in Cerebral Thromboemboli
por: Essig, Fabian, et al.
Publicado: (2021)

Urinary and serum levels of high mobility group box 1
por: Nakamura, Toshihiko, et al.
Publicado: (2023)

High Mobility Group Box-1: A Missing Link between Diabetes and Its Complications
por: Wu, Han, et al.
Publicado: (2016)

The Proinflammatory Cytokine High-Mobility Group Box-1 Mediates Retinal Neuropathy Induced by Diabetes
por: Abu El-Asrar, Ahmed M., et al.
Publicado: (2014)

High Mobility Group Box-1 and Diabetes Mellitus Complications: State of the Art and Future Perspectives
por: Biscetti, Federico, et al.
Publicado: (2019)

Association of High-Mobility Group Box 1 (HMGB1) Gene Polymorphisms with Susceptibility and Better Survival Prognosis in Chinese Han Neonatal Necrotizing Enterocolitis
por: Cao, Huiling, et al.
Publicado: (2021)

High mobility group box 1 was associated with thrombosis in patients with atrial fibrillation
por: Xu, Qiwen, et al.
Publicado: (2018)

Identification and Characterization of the Lamprey High-Mobility Group Box 1 Gene
por: Pang, Yue, et al.
Publicado: (2012)

Expression and Effects of High-Mobility Group Box 1 in Cervical Cancer
por: Pang, Xiaoao, et al.
Publicado: (2014)

High Mobility Group Box 1 Expression in Oral Inflammation and Regeneration
por: Yamashiro, Keisuke, et al.
Publicado: (2020)

High Mobility Group Box-1 and Blood–Brain Barrier Disruption
por: Nishibori, Masahiro, et al.
Publicado: (2020)

The Roles of High Mobility Group Box 1 in Cerebral Ischemic Injury
por: Gou, Xiaoyun, et al.
Publicado: (2020)

Role of Glycated High Mobility Group Box-1 in Gastric Cancer
por: Kishi, Shingo, et al.
Publicado: (2021)

Cytoplasmic translocation of high-mobility group box-1 protein is induced by diabetes and high glucose in retinal pericytes
por: Kim, Junghyun, et al.
Publicado: (2016)

The role of High Mobility Group Box 1 (HMGB1) in colorectal cancer
por: Süren, Dinç, et al.
Publicado: (2014)

High-mobility group box-1 and biomarkers of inflammation in the vitreous from patients with proliferative diabetic retinopathy
por: El-Asrar, Ahmed M. Abu, et al.
Publicado: (2011)

Etanercept ameliorates psoriasis progression through regulating high mobility group box 1 pathway
por: Li, Shu, et al.
Publicado: (2023)

High Mobility Group Box 1 Protein Induction by Mycobacterium Bovis BCG
por: Hofner, Péter, et al.
Publicado: (2007)

Bench-to-bedside review: High-mobility group box 1 and critical illness
por: Fink, Mitchell P
Publicado: (2007)

High mobility group box-1 protein – one step closer to the clinic?
por: Mollnes, Tom Eirik
Publicado: (2008)

Unraveling the role of high mobility group box protein 1 in severe trauma
por: Abraham, Edward
Publicado: (2009)

High mobility group box-1 recognition: The beginning of a RAGEless era?
por: Branco-Madeira, Filipe, et al.
Publicado: (2010)

High mobility group box-1 and its clinical value in breast cancer
por: Sun, Shanping, et al.
Publicado: (2015)

Clinical and prognostic significance of high-mobility group box-1 in human gliomas
por: WANG, XIN-JUN, et al.
Publicado: (2015)

The Effects of Remifentanil on Expression of High Mobility Group Box 1 in Septic Rats
por: Seo, Kwon hui, et al.
Publicado: (2017)

The role of high mobility group box 1 protein in acute cerebrovascular diseases
por: Mu, Shu-Wen, et al.
Publicado: (2018)

High Mobility Group Box 1 Mediates TMAO-Induced Endothelial Dysfunction
por: Singh, Gurinder Bir, et al.
Publicado: (2019)

Molecular isoforms of high-mobility group box 1 are mechanistic biomarkers for epilepsy
por: Walker, Lauren Elizabeth, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_r476tmisgc1jplh74b4lgdjb1k